EUCTR2014-003964-18-Outside-EU/EEA进行中（未招募）不适用
Evaluation of the Pharmacokinetics of Saxagliptin, 5-Hydroxy Saxagliptin, and Metformin in Children and Adolescents Aged 10 to 17 Years with Type 2 Diabetes Mellitus Following Oral Administration of Saxagliptin and Metformin XR Fixed Dose Combination Tablet and Co-Administration of Saxagliptin and Glucophage® (Metformin) IR Tablets
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Clinical diagnosis of T2DM
- •Male and female subjects ages 10-17
- •Body weight =50 kg
- •Glycosylated hemoglobin (HbA1c) 6.5 to 10%
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 12
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Fasting plasma glucose (FPG) > 240 mg/dL at screening
- •Abnormal renal function
- •Active liver disease and/or significant abnormal liver function
研究者
相似试验
未知
3 期
A clinical pharmacology study of saxagliptin in patients with type 2 diabetes mellitusJPRN-jRCT2080221155Otsuka Pharmaceutical Co., Ltd.20
已完成
3 期
A Clinical Pharmacology Study of Saxagliptin in Patients With Type 2 Diabetes MellitusDiabetesNCT01162876Kyowa Kirin Co., Ltd.20
终止
1 期
Study of Saxagliptin, 5-Hydroxy Saxagliptin, and Metformin Concentrations/Levels in Pediatric Subjects With T2DMType 2 Diabetes MellitusNCT01525225AstraZeneca4
已完成
1 期
A Bioequivalence Study of the Fixed Dose Combinations of Saxagliptin/Metformin XR Relative to Co-AdministrationType 2 Diabetes Mellitus(T2DM)NCT01755494AstraZeneca64
进行中（未招募）
1 期
Effect of Saxagliptin in Addition to Dapagliflozin and Metformin on Insulin Resistance, Islet Cell Dysfunction, and Metabolic Control in Subjects with Type 2 Diabetes Mellitus on Previous Metformin TreatmentEUCTR2014-003788-39-DEProfil Mainz GmbH & Co KG